Skip to search formSkip to main contentSkip to account menu

RDEA806

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Discovery of potent HIV-1 non-nucleoside reverse transcriptase inhibitors from arylthioacetanilide structural motif.
2010
2010
Antiretroviral-Naïve Subjects Inhibitor , RDEA 806 , in HIV-1-Positive , Nonnucleoside Reverse Transcriptase Pharmacokinetics of a Novel Short-Term Activity , Safety , and Phase 2 a Randomized…
Published Ahead of Print 24 May 2010. 10.1128/AAC.00268-10. 2010, 54(8):3170. DOI: Antimicrob. Agents Chemother. Voon Ong, Li… 
2008
2008
RDEA806, a Novel HIV Non-Nucleoside Reverse Transcriptase Inhibitor, Shows Positive Outcome in Treatment of Näive HIV Patients
2008
2008
Resistance to RDEA806 Requires Multiple Mutations Which Have Limited Cross-resistance to Other NNRTIs
2008
2008
New Agents: IDX899, RDEA806, and Apricitabine
Most of the action around new antiretrovirals at the 2008 International AIDS Conference centered on second-generation NNRTIs… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)